36-2514
|
36-2514. Substances in schedule III; definition A. The following controlled substances are, unless specifically excepted, included in schedule III: 1. Any material, compound, mixture or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system, including its salts, isomers, whether optical, position or geometric, and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation: (a) Benzphetamine. (b) Chlorphentermine. (c) Clortermine. (d) Delta-9-tetrahydrocannabinol (synthetic). (e) Gamma-hydroxybutyric acid, any salt, hydroxybutyric compound, derivative or preparation of gamma-hydroxybutyric acid, including isomers, esters and ethers and salts of isomers, esters and ethers of gamma-hydroxybutyric acid, except gamma-butyrolactone, contained in a drug product for which an application has been approved under section 505 of the federal food, drug and cosmetic act. (f) Ketamine. (g) Phendimetrazine. 2. Any material, compound, mixture or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system: (a) Any compound, mixture or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule. (b) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital or any salt of any of these drugs and approved by the federal act for marketing only as a suppository. (c) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof. (d) Chlorhexadol. (e) Lysergic acid. (f) Lysergic acid amide. (g) Methyprylon. (h) Sulfondiethylmethane. (i) Sulfonethylmethane. (j) Sulfonmethane. (k) Tiletamine/zolazepam (telazol). 3. Any material, compound, mixture or preparation containing the narcotic drug nalorphine or any of its salts. 4. Any material, compound, mixture or preparation containing the narcotic drug buprenorphine or any of its salts. 5. Any material, compound, mixture or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof, calculated as the free anhydrous base or alkaloid: (a) Not more than one point eight grams of codeine, or any of its salts, per one hundred milliliters or not more than ninety milligrams per dosage unit with an equal or greater quantity of an isoquinoline alkaloid of opium. (b) Not more than one point eight grams of codeine, or any of its salts, per one hundred milliliters or not more than ninety milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts. (c) Not more than three hundred milligrams of dihydrocodeinone, or any of its salts, per one hundred milliliters or not more than fifteen milligrams per dosage unit with a fourfold or greater quantity of an isoquinoline alkaloid of opium. (d) Not more than three hundred milligrams of dihydrocodeinone, or any of its salts, per one hundred milliliters or not more than fifteen milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts. (e) Not more than one point eight grams of dihydrocodeine, or any of its salts, per one hundred milliliters or not more than ninety milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts. (f) Not more than three hundred milligrams of ethylmorphine, or any of its salts, per one hundred milliliters or not more than fifteen milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts. (g) Not more than five hundred milligrams of opium per one hundred milliliters or per one hundred grams or not more than twenty-five milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts. (h) Not more than fifty milligrams of morphine, or any of its salts, per one hundred milliliters or per one hundred grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts. 6. Any material, compound, mixture or preparation containing any of the following anabolic steroids but not including United States food and drug administration approved over-the-counter preparations, labeled for animal use or those prescription-only anabolic steroid preparations in combination with a therapeutic amount of a nonanabolic steroid and intended for human use: (a) Boldenone. (b) Chlorotestosterone. (c) Clostebol. (d) Dehydrochlormethyltestosterone. (e) Dihydrotestosterone. (f) Drostanolone. (g) Ethylestrenol. (h) Fluoxymesterone. (i) Formebulone. (j) Mesterolone. (k) Methandienone. (l) Methandranone. (m) Methandriol. (n) Methandrostenolone. (o) Methenolone. (p) Methyltestosterone. (q) Mibolerone. (r) Nandrolone. (s) Norethandrolone. (t) Oxandrolone. (u) Oxymesterone. (v) Oxymetholone. (w) Stanolone. (x) Stanozolol. (y) Testolactone. (z) Testosterone. (aa) Trenbolone. (bb) Any salt, ester or isomer of a drug or substance described or listed in this paragraph, if that salt, ester or isomer promotes muscle growth. B. The board may except by rule any compound, mixture or preparation containing any substance listed in this section from the application of all or any part of this chapter if the compound, mixture or preparation contains one or more active medicinal ingredients and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiates the potential for abuse. C. For the purposes of this section, "anabolic steroid" means a growth promoting drug or hormonal substance that is chemically or pharmacologically related to testosterone, other than estrogens, progestins and corticosteroids. |